期刊文献+

克拉霉素磷脂复合物制备工艺的研究 被引量:3

Preparation technology research of clarithromycin-phospholipid complex
下载PDF
导出
摘要 目的确定克拉霉素与磷脂形成复合物的最佳工艺。方法采用溶剂挥发法制备免摭霉素磷脂复合物,以复合率为评价指标进行单因素优化实验和正交试验。结果优化条件下制备的磷脂复合物复合率为95.2%~98.2%。结论克拉霉素磷脂复合物的形成受反应溶剂、反应物浓度、和反应物投料比例和反应温度的影响较人。 Objective To determine the best technology of clarithromycin-phospholipid complex. Methods The complex was prepared using solvent evaporation method. The preparation technology was optimized by single factor design and orthogonal experiment, using the combining ratio as the assessment index. Results The combining ratio of the complex prepared under the optimized conditions was between 95.2% and 98.2%. Conclusions The formation of clarithromycin-phospholipid complex reactant ratio and reaction temperature. was influenced by reaction solvent, concentration of reactant,
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2014年第4期282-284,310,共4页 Chinese Journal of Antibiotics
关键词 克拉霉素磷脂复合物 克拉霉素 复合率 Clarithromycin-phospholipid complex (CPC) Clarithromycin Combining ratio
  • 相关文献

参考文献10

  • 1Peter D H, Clissold S P. Clarithromycin: a review of its antimicrobial activity, pharmaceutical properties and therapeutic potential[J]. Drugs, 1992, 44(1): 117 - 164.
  • 2Langtry H D, Brogden R N. Clarithromycin: a review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients[J]. Drugs, 1997, 53: 973-1004.
  • 3Anderson R, Joone G, Rensburg E J. An in vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin, a new macrolide antimicrobial agent[J]. JAntimicrob Chemother, 1988, 22: 923-933.
  • 4Celis G, Gea E, Roig J. Comparative tolerability of intravenous erythromycin and clarithromycin in hospitalised patients with community-acquired pneumonia results of a double-blind, randomized, prospective study[J]. Clin Drug Invest, 2002, 22: 393-398.
  • 5Torsten Z, Heinrich L, Klaus D R, et al. Comparative tolerability of intravenous azithromycin, clarithromycin and erythromycin in healthy volunteers results of a double-blind double-dummy, four-way crossover study[J]. Clin Drug Invest, 2001, 21: 527-536.
  • 6Caillot D, Casasnovas O, Solary E, et al. Efficacy and tolerance of an amphotericin B lipid (intralipid) emulsion in the treatment of candidaemia in neutropenic patients[J]. JAntimicrob Chemother, 1993, 31 : 161 - 169.
  • 7Menashe Y L, Lev L, Shoshanna G S, et al. Sideffect evaluation of a new diazepam formulation., venous sequela reduction following intravenous (iv) injection of a diazepam emulsion in rabbits[J]. Pharm Res, 1989, 6: 510-516.
  • 8Eugene H C, Catherijen A K, Victorine S K, et al. Influence of different fat emulsion based intravenous formulation on the pharmacokinetics and pharmaco-dynamics of propfol[J]. Pharm Res, 1998, 15: 442-448.
  • 9Toichi T, Kiyoshi K, Yoshinobu T, et al. Long circulating emulsion carrier systems for highly lipophilic drugs[J]. Biol Pharm Bull, 1994, 17: 121-125.
  • 10冯年平,范广平.天然药物传递系统-磷脂复合物[J].中国中医药信息杂志,2001,8(3):34-35. 被引量:10

二级参考文献3

共引文献9

同被引文献21

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部